NEXAVAR HAS NOT SHATTERED THE DREAM.it is a misunderstanding from investors here.my information still says progens cancer drug is on track. the competition
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game